| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
107.97(B) |
| Last
Volume: |
3,217,222 |
Avg
Vol: |
8,418,111 |
| 52
Week Range: |
$48.64 - $75.67 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
312,036 |
508,687 |
1,007,678 |
2,119,191 |
| Total Sell Value |
$23,117,519 |
$34,902,586 |
$61,221,104 |
$110,722,184 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
27 |
44 |
79 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Carruthers Wendy |
EVP, Human Resources |
• • – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
90,346 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2023-02-15 |
4 |
AS |
$47.14 |
$356,927 |
D/D |
(7,572) |
276,316 |
|
13% |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2023-02-15 |
4 |
D |
$47.29 |
$57,647 |
D/D |
(1,219) |
283,888 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2023-02-15 |
4 |
OE |
$0.00 |
$55,957 |
D/D |
11,725 |
285,107 |
|
- |
|
| Brown Vance R |
SVP, GC and Corp. Secretary |
• • – |
2023-02-15 |
4 |
D |
$47.29 |
$15,275 |
D/D |
(323) |
38,602 |
|
- |
|
| Brown Vance R |
SVP, GC and Corp. Secretary |
• • – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
923 |
38,925 |
|
- |
|
| Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
• • – |
2023-02-15 |
4 |
D |
$47.29 |
$38,731 |
D/D |
(819) |
24,419 |
|
- |
|
| Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
• • – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,846 |
25,238 |
|
- |
|
| Monson Jonathan |
SVP, Global Controller and CAO |
• • – |
2023-02-15 |
4 |
D |
$47.29 |
$16,079 |
D/D |
(340) |
33,001 |
|
- |
|
| Monson Jonathan |
SVP, Global Controller and CAO |
• • – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
739 |
33,341 |
|
- |
|
| Sorenson John Bradley |
EVP, Global Operations |
• • – |
2023-02-15 |
4 |
D |
$47.29 |
$25,915 |
D/D |
(548) |
35,659 |
|
- |
|
| Sorenson John Bradley |
EVP, Global Operations |
• • – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,200 |
36,207 |
|
- |
|
| Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
• • – |
2023-02-15 |
4 |
D |
$47.29 |
$29,414 |
D/D |
(622) |
89,888 |
|
- |
|
| Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
• • – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,031 |
90,510 |
|
- |
|
| Mahoney Michael F |
Chairman, President & CEO |
• • – |
2023-02-15 |
4 |
D |
$47.29 |
$387,116 |
D/D |
(8,186) |
1,813,151 |
|
- |
|
| Mahoney Michael F |
Chairman, President & CEO |
• • – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,457 |
1,821,337 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
• • – |
2023-02-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,000 |
209,827 |
|
- |
|
| Carruthers Wendy |
EVP, Human Resources |
• • – |
2023-02-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,195 |
88,685 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
• • – |
2023-02-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
630 |
4,344 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
• • – |
2023-02-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,520 |
220,827 |
|
- |
|
| Sorenson John Bradley |
EVP, Global Operations |
• • – |
2023-02-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,779 |
35,007 |
|
- |
|
| Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
• • – |
2023-02-03 |
4 |
S |
$48.74 |
$1,316,037 |
D/D |
(27,000) |
23,392 |
|
-10% |
|
| Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
• • – |
2023-02-03 |
4 |
OE |
$16.31 |
$249,206 |
D/D |
15,034 |
50,392 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2023-01-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,201 |
0 |
|
- |
|
| Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
• • – |
2023-01-04 |
4 |
AS |
$46.38 |
$313,123 |
D/D |
(6,751) |
88,479 |
|
15% |
|
2518 Records found
|
|
Page 13 of 101 |
|
|
0.07 (0.09%) 
